A study to evaluate ecopipam in children, adolescents and adults with Tourette's disorder (H-53025)

A multicenter, double-blind, placebo-controlled, randomized withdrawal study to evaluate the safety and maintenance of efficacy of ecopipam in children, adolescents and adults with Tourette's disorder

The purpose of this study is to evaluate if the study drug, Ecopipam, is better in patients with Tourette’s Disorder and tics, compared to those patients who don’t take any medications. Ecopipam is an experimental drug, which means that the FDA has not approved it for the treatment of Tourette Disorder or any other indication.